These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 21630304
1. Biomarkers for early detection of sickle nephropathy. Sundaram N, Bennett M, Wilhelm J, Kim MO, Atweh G, Devarajan P, Malik P. Am J Hematol; 2011 Jul; 86(7):559-66. PubMed ID: 21630304 [Abstract] [Full Text] [Related]
2. Glomerular and tubular damage markers are elevated in patients with diabetes. Nauta FL, Boertien WE, Bakker SJ, van Goor H, van Oeveren W, de Jong PE, Bilo H, Gansevoort RT. Diabetes Care; 2011 Apr; 34(4):975-81. PubMed ID: 21307379 [Abstract] [Full Text] [Related]
3. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction. Holzscheiter L, Beck C, Rutz S, Manuilova E, Domke I, Guder WG, Hofmann W. Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749 [Abstract] [Full Text] [Related]
4. Urinary Kidney Injury Molecules in Children with Iron-Deficiency Anemia. Güneş A, Ece A, Aktar F, Tan İ, Söker M, Karabel D, Balık H, Uluca Ü, Şen V, Yolbaş İ. Med Sci Monit; 2015 Dec 24; 21():4023-9. PubMed ID: 26697893 [Abstract] [Full Text] [Related]
5. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study. Fu WJ, Xiong SL, Fang YG, Wen S, Chen ML, Deng RT, Zheng L, Wang SB, Pen LF, Wang Q. Endocrine; 2012 Feb 24; 41(1):82-8. PubMed ID: 21779943 [Abstract] [Full Text] [Related]
6. Establishment of reference values for novel urinary biomarkers for renal damage in the healthy population: are age and gender an issue? Pennemans V, Rigo JM, Faes C, Reynders C, Penders J, Swennen Q. Clin Chem Lab Med; 2013 Sep 24; 51(9):1795-802. PubMed ID: 23648635 [Abstract] [Full Text] [Related]
10. Evidence of uncoupling between renal dysfunction and injury in cardiorenal syndrome: insights from the BIONICS study. Legrand M, De Berardinis B, Gaggin HK, Magrini L, Belcher A, Zancla B, Femia A, Simon M, Motiwala S, Sambhare R, Di Somma S, Mebazaa A, Vaidya VS, Januzzi JL, Global Research on Acute Conditions Team (GREAT)AP-HP, Groupe hospitalier St-Louis-Lariboisière, Department of Anesthesiology and Critical Care and Burn unit, F-75475, Paris, France.. PLoS One; 2014 Sep 24; 9(11):e112313. PubMed ID: 25386851 [Abstract] [Full Text] [Related]
14. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study. Bhavsar NA, Köttgen A, Coresh J, Astor BC. Am J Kidney Dis; 2012 Aug 24; 60(2):233-40. PubMed ID: 22542304 [Abstract] [Full Text] [Related]
15. Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA). Peralta CA, Katz R, Bonventre JV, Sabbisetti V, Siscovick D, Sarnak M, Shlipak MG. Am J Kidney Dis; 2012 Dec 24; 60(6):904-11. PubMed ID: 22749388 [Abstract] [Full Text] [Related]